Parathyroid tumors are the most common clinical manifestation, and the prevalence of hyperparathyroidism is >90% in patients with MEN1, whereas those of pancreatic and pituitary tumors are 40–70% and 30–60%, respectively [2]. The gene discussed is MEN1; the disease is tumor of parathyroid gland.